Fig. 2From: In silico evaluation of some 4-(quinolin-2-yl)pyrimidin-2-amine derivatives as potent V600E-BRAF inhibitors with pharmacokinetics ADMET and drug-likeness predictionsa 2D diagram for the interaction of compound 5 with V600E-BRAF, b 3D view of the compound 5 in the binding site of V600E-BRAFBack to article page